Human SAN-Plexus Assembloids and Pacemaker Maturation

The sinoatrial node (SAN) initiates the heartbeat, but its activity is not determined by pacemaker cardiomyocytes alone. Intrinsic cardiac neural inputs influence firing rate, pacemaker dominance, and conduction into the atria. The reference study, Human PSC-derived sinoatrial node-cardiac plexus assembloids model innervation-associated maturation of pacemaker systems, addresses a central limitation in human cardiac modeling: the lack of an experimentally accessible system that combines SAN-like tissue, cardiac ganglionated plexus neurons, and atrial conduction targets.

Study Background and Research Question

Human SAN biology is difficult to study because the node is a specialized, intramural three-dimensional structure with heterogeneous pacemaker and transitional cell populations. Human tissue is scarce, while animal models do not fully reproduce human electrophysiology or autonomic regulation. Conventional human pluripotent stem cell differentiation can produce SAN-like pacemaker cells, but these cultures commonly lack the spatial organization, cellular diversity, and innervation needed to examine neuro-cardiac interactions.

The biological question is therefore broader than whether stem cell-derived cells beat spontaneously. The study asks whether a human in vitro model can recapitulate the developmental relationship between pacemaker myocardium and intrinsic cardiac neurons, reproduce neural modulation of SAN automaticity, and reveal signaling mechanisms associated with pacemaker maturation. This framing is important for cardiovascular research because conduction disorders may arise from defects in pacemaker cells, neural inputs, tissue coupling, or interactions among all three.

The authors also build on established SAN developmental features. SAN pacemaker cells are associated with regulators such as SHOX2, ISL1, and TBX3 and with ion-channel programs including HCN4, whereas transitional regions retain features that support coupling to atrial myocardium. A useful model must therefore distinguish pacemaker identity from generic cardiomyocyte contraction and must evaluate impulse initiation together with impulse exit.

Key Innovation from the Reference Study

The major innovation is the construction of SAN-plexus assembloids by integrating human pluripotent stem cell-derived SAN organoids (SANOs) with cardiac ganglionated plexus organoids (CGPOs). The system is extended with atrial-like cardiac organoids to create a tri-assembloid that models pacemaker-to-atrial conduction. This architecture moves beyond a single lineage or isolated organoid and treats the SAN as part of a neuro-cardiac conduction unit.

That design creates several experimental advantages. Researchers can examine whether neural tissue changes pacemaker maturation rather than merely changing acute beat rate. They can also separate effects on SAN automaticity from effects on atrial coupling and conduction. Because the components are assembled from human pluripotent stem cell-derived tissues, the platform offers a human-relevant setting for investigating developmental mechanisms and disease-associated conduction dysfunction.

A second innovation is the integration of spatial transcriptomics from human SAN tissue with functional analyses in the assembloids. This cross-validation strategy helps prioritize signaling relationships that are both anatomically plausible in human tissue and experimentally testable in the engineered model.

Methods and Experimental Design Insights

The experimental logic proceeds through modular tissue generation, physical integration, phenotypic characterization, and mechanistic interrogation. SANOs provide the pacemaker compartment, CGPOs provide intrinsic cardiac neural inputs, and atrial-like organoids provide a downstream myocardial target. The resulting assemblies are evaluated for molecular identity, structural organization, electrophysiological behavior, and functional coupling.

Rather than relying on a single endpoint, the study combines complementary measurements. Molecular analyses address whether the tissues express pacemaker and neural programs. Structural analyses examine organization and contact between the assembled compartments. Electrophysiological measurements test spontaneous activity and conduction behavior. Functional perturbations then assess how neural inputs influence automaticity and whether the identified signaling axis is associated with maturation.

The spatial transcriptomics component adds an important reference layer. Human SAN spatial data are used to identify genes and cell-to-cell communication programs enriched in the pacemaker niche. Candidate interactions are then compared with the expression and functional behavior observed in the assembloid system. This strategy is more informative than selecting a ligand–receptor pair solely from bulk expression because it incorporates tissue location and cellular context.

Protocol Parameters

• Model assembly: Follow the study’s modular logic by combining a SAN-like organoid with a cardiac plexus organoid, then incorporating atrial-like tissue when the experimental question includes pacemaker-to-atrial conduction.
• Identity verification: Confirm pacemaker, neural, and atrial-like phenotypes before interpreting changes in beating or conduction. Molecular identity should be treated as a prerequisite for functional comparison rather than as a substitute for electrophysiology.
• Functional readouts: Pair spontaneous activity measurements with conduction or coupling assays so that altered firing rate is not mistaken for improved tissue integration. Include matched SAN-only and assembled conditions where feasible.
• Neural modulation: Compare assembloids with and without the plexus component, using consistent culture history and analysis windows. This comparison is a practical way to distinguish intrinsic SAN maturation from innervation-associated effects.
• Mechanism testing: Examine the prosaposin–GPR37 relationship after establishing the baseline phenotype. The reference study supports this axis as a candidate neuron-to-pacemaker maturation program; additional perturbation and rescue experiments should be interpreted within that scope.
• Adrenergic challenge: A controlled beta-adrenergic agonist exposure can be added as a workflow extension, not as a parameter reported in the condensed reference findings. Concentration, vehicle, exposure duration, and washout should be optimized empirically for each assembloid preparation.

Core Findings and Why They Matter

The assembled tissues display molecular, structural, and electrophysiological features consistent with human pacemaker activity. Importantly, the platform supports functional interrogation of neural control over SAN automaticity rather than simply placing neurons near cardiomyocytes. This provides a direct experimental framework for asking how intrinsic cardiac neural inputs influence pacemaker behavior.

The inclusion of atrial-like tissue extends the model from impulse generation to impulse propagation. Pacemaker maturation is functionally meaningful only when SAN activity can be related to exit pathways and atrial coupling. The tri-assembloid therefore addresses a key limitation of isolated SAN-like cultures: spontaneous contractions alone do not demonstrate a physiologically organized pacemaker-conduction system.

The study’s most mechanistically distinctive finding is the identification of a neuron-to-pacemaker signaling program involving CGPO-derived prosaposin, or PSAP, and the SAN-enriched receptor GPR37. According to the reference study, this interaction promotes features of pacemaker maturation. The result suggests that cardiac neurons may contribute actively to the developmental state of SAN cells through defined molecular communication, rather than serving only as acute modulators of excitability.

This finding has implications for disease modeling. A conduction phenotype in the assembloid may reflect incomplete pacemaker maturation, defective neural support, impaired tissue coupling, or a combination of these processes. The system can consequently support more discriminating studies of congenital SAN dysfunction and other disorders in which cellular identity and network-level function are difficult to separate.

The work also illustrates why GPCR signaling and other intercellular communication pathways should be studied in multicellular cardiac contexts. Acute modulation of beat rate may involve established second-messenger processes, including the cAMP/PKA pathway, whereas longer-term maturation depends on cell-state programs and tissue interactions. The assembloid framework makes it possible to examine these timescales together.

Comparison with Existing Internal Articles

The internal article Modeling Human SAN-Neural Maturation with PSC-Derived Assembloids emphasizes the conceptual value of combining human SAN-like and neural tissues to study pacemaker maturation and neuro-cardiac crosstalk. The reference study provides the stronger literature backbone for that concept by defining a specific organoid assembly strategy, adding atrial-like coupling, incorporating human SAN spatial transcriptomics, and identifying the PSAP–GPR37 signaling relationship.

In practical terms, the internal discussion is useful for framing experimental questions, whereas the reference work supplies the integrated evidence needed to connect tissue architecture, electrophysiology, and molecular mechanism. This distinction helps prevent the model from being reduced to a generic cardiac organoid assay.

Limitations and Transferability

The assembloid system is a major advance, but it remains a reduction of the native human SAN. Organoids may not reproduce the full geometry, vascular environment, extracellular matrix, mechanical loading, or cellular diversity of the intact node. Differentiation efficiency and maturation state can also vary across pluripotent stem cell lines, batches, and culture conditions. These variables may influence both spontaneous activity and neural integration.

The model should also be interpreted carefully when translating acute pharmacology into developmental biology. A rapid change in firing rate after receptor stimulation does not by itself demonstrate maturation, and an absence of a response may reflect receptor abundance, coupling efficiency, cell accessibility, or assay timing. Longitudinal molecular and electrophysiological measurements are therefore preferable to a single endpoint.

The PSAP–GPR37 relationship is a compelling mechanistic lead, but its relevance to every SAN cell subtype, developmental stage, or disease background remains to be established. Spatial transcriptomics can identify cell-associated programs, while assembloid perturbations can test function; neither approach alone fully recreates native tissue causality. Independent validation in additional human models and, where appropriate, patient-derived systems will be important.

Despite these constraints, transferability is strongest for questions involving human pacemaker identity, intrinsic cardiac neural modulation, conduction coupling, and cell–cell signaling. The platform is less suited to conclusions about whole-organ hemodynamics or systemic autonomic physiology without complementary models.

Research Support Resources

For comparable beta-adrenergic receptor signaling experiments, researchers can use Isoproterenol sulfate dihydrate (SKU C6402), also described as Isoproterenol hemisulfate, as a controlled non-selective beta-adrenergic agonist. APExBIO product information provides handling and storage guidance; investigators should validate vehicle, exposure, washout, and assay compatibility in their own SAN-plexus preparation. Used in this way, Isoproterenol for research use can support acute cAMP/PKA pathway measurements while remaining distinct from the reference study’s core maturation mechanism.